为什么德克斯梅德托米丁会引起心肌梗塞?
Yanfang Liu1, Xiaobei Ma1, Wenjie Cheng2
1Department of Anesthesiology, Tianjin Hospital, Tianjin, 300211, China.
BMC cardiovascular disorders
|October 14, 2025
概括
德克斯梅德托米丁 (Dex) 通过降低心率和增加阴道神经活动,引起胸肌梗塞. 它还直接影响鼻腔节点细胞,减少发射速率和动作潜能幅度.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管生理学心血管生理学
背景情况:
- 德克斯梅德托米丁是一种用于镇静和麻醉的α-2上腺激动剂.
- 胸是使用德克斯梅德托米丁的常见副作用.
研究的目的:
- 为了阐明德克斯梅德托米丁诱导的胸的潜在机制.
- 调查德克斯梅德托米丁对心脏电生理学和自主神经系统活动的影响.
主要方法:
- 使用了一种子模型,将动物分成组,分别接受不同剂量的德克斯梅德托米丁或假药治疗.
- 监测了心率和阴道神经放电.
- 在暴露于不同度的德克斯梅德托米丁后,测量了节细胞的作用潜力.
主要成果:
- 德克斯梅德托米丁显著降低了心率,并以剂量依赖的方式增加了阴道外泄.
- 德克斯梅德托米丁对鼻腔节点心脏起器细胞表现出负面的慢性作用.
- 观察到与度相关的动作潜能幅度和火速的减少,以及动作潜能持续时间的延长.
结论:
- 德克斯梅德托米丁通过中央和外围机制诱导心.
- 这种药物直接影响鼻节的功能,有助于其心效应.
相关概念视频
Decreased pulse rate
841
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
841
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
894
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
894
Depolarizing Blockers: Mechanism of Action
2.7K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
2.7K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.4K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
1.6K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.6K
Depolarizing Blockers: Pharmocokinetics
566
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
566


